Search by Drug Name or NDC

    NDC 71288-0115-30 Azacitidine 100 mg/30mL Details

    Azacitidine 100 mg/30mL

    Azacitidine is a INTRAVENOUS; SUBCUTANEOUS INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Meitheal Pharmaceuticals Inc.. The primary component is AZACITIDINE.

    Product Information

    NDC 71288-0115
    Product ID 71288-115_43ffb0fa-6810-49e4-acda-0ef79bfcffcb
    Associated GPIs 21300003001920
    GCN Sequence Number 054660
    GCN Sequence Number Description azacitidine VIAL 100 MG INJECTION
    HIC3 V1B
    HIC3 Description ANTINEOPLASTIC - ANTIMETABOLITES
    GCN 22663
    HICL Sequence Number 026361
    HICL Sequence Number Description AZACITIDINE
    Brand/Generic Generic
    Proprietary Name Azacitidine
    Proprietary Name Suffix n/a
    Non-Proprietary Name Azacitidine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
    Route INTRAVENOUS; SUBCUTANEOUS
    Active Ingredient Strength 100
    Active Ingredient Units mg/30mL
    Substance Name AZACITIDINE
    Labeler Name Meitheal Pharmaceuticals Inc.
    Pharmaceutical Class Nucleic Acid Synthesis Inhibitors [MoA], Nucleoside Metabolic Inhibitor [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA212128
    Listing Certified Through 2024-12-31

    Package

    NDC 71288-0115-30 (71288011530)

    NDC Package Code 71288-115-30
    Billing NDC 71288011530
    Package 1 VIAL, SINGLE-DOSE in 1 CARTON (71288-115-30) / 30 mL in 1 VIAL, SINGLE-DOSE
    Marketing Start Date 2020-11-02
    NDC Exclude Flag N
    Pricing Information N/A